Stay updated on Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial

Sign up to get notified when there's something new on the Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:36:48.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the usual study record content. The standard study details and navigation are not accessible on this page.
    Difference
    17%
    Check dated 2026-09-19T19:36:37.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The study page's revision tag was updated from v3.6.5 to v3.6.6, indicating a minor metadata update to the record. No substantive study content appears to be changed.
    Difference
    0.1%
    Check dated 2026-08-29T20:17:42.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The study page now includes expanded MeSH terms and related metadata. This enhances indexing and cross-referencing without changing enrollment, design, or results.
    Difference
    51%
    Check dated 2026-08-16T01:16:29.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.4 to v3.6.5, signaling a newer version of the ClinicalTrials.gov entry. This reflects an update to the page metadata or minor content refinements without altering the study's data or eligibility details.
    Difference
    0.1%
    Check dated 2026-08-08T23:23:15.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page footer now shows revision v3.6.4, replacing v3.6.3. This appears to be a minor system update and does not modify the study information.
    Difference
    0.1%
    Check dated 2026-07-25T17:15:00.000Z thumbnail image

Stay in the know with updates to Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial page.